Jürgen C. Becker

34.2k total citations · 6 hit papers
465 papers, 20.1k citations indexed

About

Jürgen C. Becker is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Jürgen C. Becker has authored 465 papers receiving a total of 20.1k indexed citations (citations by other indexed papers that have themselves been cited), including 258 papers in Oncology, 157 papers in Immunology and 101 papers in Molecular Biology. Recurrent topics in Jürgen C. Becker's work include Polyomavirus and related diseases (105 papers), Immunotherapy and Immune Responses (105 papers) and Full-Duplex Wireless Communications (65 papers). Jürgen C. Becker is often cited by papers focused on Polyomavirus and related diseases (105 papers), Immunotherapy and Immune Responses (105 papers) and Full-Duplex Wireless Communications (65 papers). Jürgen C. Becker collaborates with scholars based in Germany, United States and Denmark. Jürgen C. Becker's co-authors include David Schrama, Per thor Straten, Mads Hald Andersen, Ralph A. Reisfeld, Roland Houben, Frank Schwarz, Narja Sahm, Selma Ugurel, Dirk Schadendorf and Frank Schwarz and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Jürgen C. Becker

438 papers receiving 19.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution

2016 598 citations Jürgen C. Becker, Per thor Straten et al. profile →
Antibody targeted drugs as cancer therapeutics

2006 597 citations David Schrama, Ralph A. Reisfeld et al. profile →
Merkel cell carcinoma

2017 377 citations Jürgen C. Becker, Andreas Stang et al. profile →
Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline

2015 371 citations Jürgen C. Becker, Claus Garbe et al. profile →
Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline

2015 340 citations Claus Garbe, Jürgen C. Becker et al. profile →
Analysis of Oral Papillomas, Leukoplakias, and Invasive Carcinomas for Human Papillomavirus Type Related DNA

1985 227 citations Jürgen C. Becker et al. profile →

Peers

Countries citing papers authored by Jürgen C. Becker

Since Specialization

Citations

This map shows the geographic impact of Jürgen C. Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jürgen C. Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jürgen C. Becker more than expected).

Fields of papers citing papers by Jürgen C. Becker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jürgen C. Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jürgen C. Becker. The network helps show where Jürgen C. Becker may publish in the future.

Co-authorship network of co-authors of Jürgen C. Becker

This figure shows the co-authorship network connecting the top 25 collaborators of Jürgen C. Becker. A scholar is included among the top collaborators of Jürgen C. Becker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jürgen C. Becker. Jürgen C. Becker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	S1‐Guideline Sebaceous Carcinoma 2024 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Jochen Utikal, (unknown), Verena Müller, Jürgen C. Becker, Edgar Dippel, (unknown), (unknown), Klaus Griewank, Eva Hadaschik, Doris Helbig, Uwe Hillen, Ulrike Leiter, Claudia Pföhler, (unknown), Mirjana Ziemer, Selma Ugurel	3
2	Introducing MCC-PS: a novel prognostic score for Merkel cell carcinoma 2024 ·Frontiers in Oncology ·Nessr Abu Rached, Jürgen C. Becker, Anke S. Lonsdorf, (unknown), (unknown), Thilo Gambichler	2
3	Incidence and Relative Survival of Patients with Merkel Cell Carcinoma in North Rhine-Westphalia, Germany, 2008–2021 2024 ·Cancers ·Andreas Stang, (unknown), (unknown), (unknown), Hiltraud Kajüter, Selma Ugurel, Jürgen C. Becker	1
4	Phenotypic plasticity of malignant T cells in blood and skin of a Sézary syndrome patient revealed by single cell transcriptomics 2023 ·Frontiers in Oncology ·Lukas Peiffer, Thilo Gambichler, Terkild B. Buus, (unknown), (unknown), (unknown), Ivelina Spassova, Linda Kubat, Laura Susok, René Stranzenbach, Nalini Srinivas, Niels Ødum, Jürgen C. Becker	2
5	1168P Tumor PD-L1 predicts the outcome of PD-1-based immunotherapy in metastatic melanoma depending on the type of tissue examined 2023 ·Annals of Oncology ·(unknown), Martin Kimmig, Klaus Griewank, Eva Hadaschik, Rudolf Herbst, (unknown), Jochen Utikal, Claudia Pfoehler, Jens Ulrich, Alexander Kreuter, Peter Mohr, Ralf Gutzmer, Friedegund Meier, Edgar Dippel, Julia Welzel, Jürgen C. Becker, Michael Weichenthal, Alpaslan Tasdogan, Dirk Schadendorf, (unknown)	1
6	B-cell lymphoma extra-large (Bcl-xL) is a promising drug target in Merkel cell carcinoma 2023 ·British Journal of Dermatology ·Kaiji Fan, Nalini Srinivas, Linda Kubat, (unknown), Antje Sucker, Dirk Schadendorf, Thilo Gambichler, Jürgen C. Becker	2
7	Concomitant Inhibition of FASN and SREBP Provides a Promising Therapy for CTCL 2022 ·Cancers ·(unknown), (unknown), (unknown), (unknown), (unknown), Carsten Geisler, Charlotte M. Bonefeld, (unknown), Michael Bzorek, Jürgen C. Becker, Lise Mette Rahbek Gjerdrum, Niels Ødum, Anders Woetmann	6
8	Prognostic Potential of the Baseline Pan-Immune-Inflammation Value and Neutrophil/Lymphocyte Ratio in Stage I to III Melanoma Patients 2022 ·Cancers ·Thilo Gambichler, Andreas Stang, (unknown), Christina Scheel, (unknown), Nessr Abu Rached, Jürgen C. Becker, Laura Susok	7
9	A digital mRNA expression signature to classify challenging Spitzoid melanocytic neoplasms 2020 ·FEBS Open Bio ·Lisa M. Hillen, Milan S. Geybels, Ivelina Spassova, Jürgen C. Becker, Thilo Gambichler, Marjan Garmyn, Axel zur Hausen, Joost van den Oord, Véronique Winnepenninckx	3
10	Characterization of six Merkel cell polyomavirus‐positive Merkel cell carcinoma cell lines: Integration pattern suggest that large T antigen truncating events occur before or during integration 2019 ·International Journal of Cancer ·David Schrama, (unknown), Christian Adam, Cathrin Ritter, Ulrike Kaemmerer, Eva Klopocki, Eva‐Maria König, Jochen Utikal, Jürgen C. Becker, Roland Houben	42
11	MHC class-I downregulation in PD-1/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition: a case series 2019 ·Cancer Immunology Immunotherapy ·Selma Ugurel, Ivelina Spassova, (unknown), Christina Drusio, (unknown), (unknown), Antje Sucker, Lisa Zimmer, Cathrin Ritter, Dirk Schadendorf, Jürgen C. Becker	70
12	Melanoma Lesions Independently Acquire T-cell Resistance during Metastatic Latency 2016 ·Cancer Research ·Fang Zhao, Antje Sucker, Susanne Horn, (unknown), Nicola Bielefeld, Barbara Schrörs, Anne Bicker, Monika Lindemann, Alexander Roesch, Gustav Gaudernack, Mathias Stiller, Jürgen C. Becker, Volker Lennerz, Thomas Wölfel, Dirk Schadendorf, Klaus Griewank, Annette Paschen	57
13	Intralesional Treatment of Stage III Metastatic Melanoma Patients with L19–IL2 Results in Sustained Clinical and Systemic Immunologic Responses 2014 ·Cancer Immunology Research ·Benjamin Weide, Thomas Eigentler, Annette Pflugfelder, Henning Zelba, Alexander Martens, Graham Pawelec, Leonardo Giovannoni, Pier Adelchi Ruffini, Giuliano Elia, Dario Neri, Ralf Gutzmer, Jürgen C. Becker, Claus Garbe	77
14	T-cell Responses to Oncogenic Merkel Cell Polyomavirus Proteins Distinguish Patients with Merkel Cell Carcinoma from Healthy Donors 2014 ·Clinical Cancer Research ·Rikke Lyngaa, Natasja Wulff Pedersen, David Schrama, Charlotte Albæk Thrue, Dafina Ibrani, Özcan Met, Per thor Straten, Paul Nghiem, Jürgen C. Becker, Sine Reker Hadrup	76
15	Neoadjuvant Imatinib in Advanced Primary or Locally Recurrent Dermatofibrosarcoma Protuberans: A Multicenter Phase II DeCOG Trial with Long-term Follow-up 2013 ·Clinical Cancer Research ·Selma Ugurel, Thomas Mentzel, Jochen Utikal, Peter Helmbold, Peter J. Mohr, Claudia Pföhler, Meinhard Schiller, Axel Hauschild, Rüdiger Hein, (unknown), (unknown), Martin Leverkus, Jürgen C. Becker, Philip Ströbel, Dirk Schadendorf	100
16	Prospective International Multicenter Phase II Trial of Intravenous Pegylated Liposomal Doxorubicin Monochemotherapy in Patients With Stage IIB, IVA, or IVB Advanced Mycosis Fungoides: Final Results From EORTC 21012 2012 ·Journal of Clinical Oncology ·Reinhard Dummer, Pietro Quaglino, Jürgen C. Becker, Baktiar Hasan, Matthias Karrasch, Sean Whittaker, Stephen Morris, Michael Weichenthal, Rudolf Stadler, M. Bagot, Antonio Cozzio, Maria Grazia Bernengo, Robert Knobler	70
17	Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma 2010 ·Journal of Clinical Oncology ·Sean Whittaker, Marie‐France Demierre, Ellen J. Kim, Alain H. Rook, Adam Lerner, Madeleine Duvic, Julia Scarisbrick, Sunil Reddy, Tadeusz Robak, Jürgen C. Becker, А. В. Самцов, William McCulloch, Youn H. Kim	480
18	Merkel Cell Polyomavirus-Infected Merkel Cell Carcinoma Cells Require Expression of Viral T Antigens 2010 ·Journal of Virology ·Roland Houben, Masahiro Shuda, (unknown), David Schrama, Huichen Feng, Yuan Chang, Patrick S. Moore, Jürgen C. Becker	339
19	A novel transgenic mouse model for immunological evaluation of carcinoembryonic antigen–based DNA minigene vaccines 2004 ·Journal of Clinical Investigation ·He Zhou, Yunping Luo, Masato Mizutani, Noriko Mizutani, Jürgen C. Becker, F. James Primus, Rong Xiang, Ralph A. Reisfeld	26
20	Long-lived and transferable tumor immunity in mice after targeted interleukin-2 therapy. 1996 ·Journal of Clinical Investigation ·Jürgen C. Becker, Nissi Varki, Stephen D. Gillies, Kaori Furukawa, R. Reisfeld	60

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact